Treatment and prognostic significance of positive interval sentinel nodes in patients with primary cutaneous melanoma

Annals of Surgical Oncology

Volumn 18, Issue 12, 2011, Pages 3292-3299

  Verwer, Nick ^a,b   Scolyer, Richard A ^a,c,d   Uren, Roger F ^a,d,e   Winstanley, Julie ^a   Brown, Philip T ^a   De Wilt, Johannes H W ^f   Thompson, John F ^a,d  

^a MELANOMA INSTITUTE AUSTRALIA   (Australia)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e Suite 304   (Australia)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY TECHNETIUM SULFIDE TC 99M;

ADOLESCENT; ADULT; AGED; ARM; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CHILD; FEMALE; HEAD; HUMAN; HUMAN TISSUE; LEG; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; NECK; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TRUNK; TUMOR BIOPSY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; YOUNG ADULT;

EID: 83055194325     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1988-5     Document Type: Article

References (21)

1. Uren RF, Howman-Giles R, Thompson JF, et al. Lymphoscintigraphy to identify sentinel nodes in patients with melanoma. Melanoma Res. 1994;4:395-9.
2. Uren RF, Howman-Giles R, Thompson JF, et al. Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg. 2000;135:1168-72.
3. McMasters KM, Chao C, Wong SL, et al. Sunbelt Melanoma Trial Group. Interval sentinel lymph nodes in melanoma. Arch Surg. 2002;137:543-7.
4. Roozendaal GK, de Vries JD, van Poll D, et al. Sentinel nodes outside lymph node basins in patients with melanoma. Br J Surg. 2001;88:305-8.
5. Scolyer RA, Murali R, McCarthy SW, Thompson JF. Pathologic examination of sentinel lymph nodes from melanoma patients. Semin Diagn Pathol. 2008;25:100-11.
6. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307-17.
7. Thompson JF, Morton DL, Kroon, B. Textbook of melanoma. 4th ed. London: Martin Dunitz; 2004.
8. van Akkooi AC, Nowecki ZI, Voit C, et al. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. Ann Surg. 2008;248:949-55.
9. Carling T, Pan D, Ariyan S, et al. Diagnosis and treatment of interval sentinel lymph nodes in patients with cutaneous melanoma. Plast Reconstr Surg. 2007;119:907-13.
10. Sumner WE III, Ross MI, Mansfield PF, et al. Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma. Cancer. 2002;95:354-60.
11. Alazraki NP, Eshima D, Eshima LA, et al. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med. 1997;27:55-67.
12. Nathanson SD, Nelson L, Karvelis KC. Rates of flow of technetium 99m-labeled human serum albumin from peripheral injection sites to sentinel lymph nodes. Ann Surg Oncol. 1996;3:329-35.
13. 99mTc sulfur colloid studies: implications for sentinel node identification in melanoma. Surgery. 1999;126:955-62.
14. Hunt JA, Thompson JF, Uren RF, et al. Epitrochlear lymph nodes as a site of melanoma metastasis. Ann Surg Oncol. 1998;5:248-52.
15. Thompson JF, Hunt JA, Culjak G, et al. Popliteal lymph node metastasis from primary cutaneous melanoma. Eur J Surg Oncol. 2000;26:172-6.
16. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-48.
17. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976-83.
18. Vidal-Sicart S, Pons F, Fuertes S, et al. Is the identification of intransit sentinel lymph nodes in malignant melanoma patients really necessary? Eur J Nucl Med Mol Imaging. 2004;31:945-9.
19. Matter M, Nicod Lalonde M, Allaoua M, et al. The role of interval nodes in sentinel lymph node mapping and dissection for melanoma patients. J Nucl Med. 2007;48:1607-13.
20. Ortín-Pérez J, Vidal-Sicart S, Doménech B, et al. In-transit sentinel lymph nodes in malignant melanoma. What is their importance? Rev Esp Med Nucl. 2008;27:424-9.
21. Chakera AH, Hansen LB, Lock-Andersen J, et al. In-transit sentinel nodes must be found: implication from a 10-year followup study in melanoma. Melanoma Res. 2008;18:359-64.